108 related articles for article (PubMed ID: 38332320)
1. Plasma proteome analysis and validation of patients with community-acquired pneumonia: A cohort study.
Zhao L; Bian W; Shang Y; Zhi H; Ma X; He Y; Yu W; Liu C; Xu Y; Gong P; Gao Z
Proteomics Clin Appl; 2024 Feb; ():e2300069. PubMed ID: 38332320
[TBL] [Abstract][Full Text] [Related]
2. Decreased plasma fetuin-A level as a novel bioindicator of poor prognosis in community-acquired pneumonia: A multi-center cohort study.
Zhao L; Shang Y; Luo Q; Ma X; Ni W; He Y; Yang D; Xu Y; Gao Z
Front Med (Lausanne); 2022; 9():807536. PubMed ID: 35966877
[TBL] [Abstract][Full Text] [Related]
3. Association of proteome and metabolome signatures with severity in patients with community-acquired pneumonia.
Gesell Salazar M; Neugebauer S; Kacprowski T; Michalik S; Ahnert P; Creutz P; Rosolowski M; ; Löffler M; Bauer M; Suttorp N; Kiehntopf M; Völker U
J Proteomics; 2020 Mar; 214():103627. PubMed ID: 31899367
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiles in community-acquired pneumonia: developing assessment tools for disease severity.
Ning P; Zheng Y; Luo Q; Liu X; Kang Y; Zhang Y; Zhang R; Xu Y; Yang D; Xi W; Wang K; Chen Y; An S; Gao Z
Crit Care; 2018 May; 22(1):130. PubMed ID: 29759075
[TBL] [Abstract][Full Text] [Related]
5. Respiratory MUC5B disproportion is involved in severe community-acquired pneumonia.
Fan L; Lu Y; Wang Y; Zhang X; Wu Y; Sun H; Zhang J
BMC Pulm Med; 2022 Mar; 22(1):90. PubMed ID: 35292003
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate biomarkers for severe adenovirus community-acquired pneumonia by proteomic approach.
Shi T; Bai J; Yang D; Huang L; Fan HF; Zhang DW; Liu T; Lu G
Heliyon; 2022 Oct; 8(10):e10807. PubMed ID: 36217477
[TBL] [Abstract][Full Text] [Related]
7. Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study.
Luo Q; Ning P; Zheng Y; Shang Y; Zhou B; Gao Z
Crit Care; 2018 Jan; 22(1):15. PubMed ID: 29368632
[TBL] [Abstract][Full Text] [Related]
8. Serum level of S100A8/A9 as a biomarker for establishing the diagnosis and severity of community-acquired pneumonia in children.
Xie S; Wang J; Tuo W; Zhuang S; Cai Q; Yao C; Han F; Zhu H; Xiang Y; Yuan C
Front Cell Infect Microbiol; 2023; 13():1139556. PubMed ID: 37180431
[TBL] [Abstract][Full Text] [Related]
9. A nomogram based on the expression level of angiopoietin-like 4 to predict the severity of community-acquired pneumonia.
Chen S; Jiang J; Su M; Chen P; Liu X; Lei W; Zhang S; Wu Q; Rong F; Li X; Zheng X; Xiao Q
BMC Infect Dis; 2023 Oct; 23(1):677. PubMed ID: 37821811
[TBL] [Abstract][Full Text] [Related]
10. The associations of serum S100A9 with the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study.
Liu HY; Xiang HX; Xiang Y; Xu Z; Feng CM; Fei J; Fu L; Zhao H
BMC Infect Dis; 2021 Apr; 21(1):327. PubMed ID: 33827454
[TBL] [Abstract][Full Text] [Related]
11. Proteome demonstration of alpha-1-acid glycoprotein and alpha-1-antichymotrypsin candidate biomarkers for diagnosis of enterovirus 71 infection.
Wang RY; Kuo RL; Yen SM; Chu CH; Wu YJ; Huang YC; Chen CJ
Pediatr Infect Dis J; 2015 Mar; 34(3):304-10. PubMed ID: 25170552
[TBL] [Abstract][Full Text] [Related]
12. Admission lysophosphatidylethanolamine acyltransferase level predicts the severity and prognosis of community-acquired pneumonia.
Chen L; Zhao L; Shang Y; Xu Y; Gao Z
Infection; 2021 Oct; 49(5):877-888. PubMed ID: 33694084
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of plasma heparin-binding protein and the heparin-binding protein-to-albumin ratio in patients with community-acquired Pneumonia: a retrospective study.
Xiao X; Hong Y; Wang S; Ma M; Xu Z
BMC Infect Dis; 2023 Nov; 23(1):777. PubMed ID: 37946099
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
[TBL] [Abstract][Full Text] [Related]
15. Surface Proteome of Plasma Extracellular Vesicles as Biomarkers for Pneumonia and Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Jung AL; Møller Jørgensen M; Bæk R; Griss K; Han M; Auf Dem Brinke K; Timmesfeld N; Bertrams W; Greulich T; Koczulla R; Hippenstiel S; Suttorp N; Schmeck B
J Infect Dis; 2020 Jan; 221(2):325-335. PubMed ID: 31617573
[TBL] [Abstract][Full Text] [Related]
16. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry.
Zheng X; Xu K; Zhou B; Chen T; Huang Y; Li Q; Wen F; Ge W; Wang J; Yu S; Sun L; Zhu L; Liu W; Gao H; Yue L; Cai X; Zhang Q; Ruan G; Zhu T; Wu Z; Zhu Y; Shao Y; Guo T; Zheng S
J Extracell Vesicles; 2020; 9(1):1750202. PubMed ID: 32363013
[No Abstract] [Full Text] [Related]
17. Serum TRAIL predicts severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study.
Hua DX; Ma KS; Cheng JY; Liu Y; Sun J; He QY; Deng YP; Yang J; Fu L; Zhao H
Intern Emerg Med; 2022 Nov; 17(8):2279-2290. PubMed ID: 36241932
[TBL] [Abstract][Full Text] [Related]
18. Cold-inducible RNA-binding protein might determine the severity and the presences of major/minor criteria for severe community-acquired pneumonia and best predicted mortality.
Guo Q; Song WD; Li HY; Li M; Chen XK; Liu H; Peng HL; Yu HQ; Liu N; Lü ZD; Liang LH; Zhao QZ; Jiang M
Respir Res; 2020 Jul; 21(1):192. PubMed ID: 32689999
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Correlation Between Serum Oncostatin-M and Disease Severity and Mortality in Hospitalized Patients with Community-Acquired Pneumonia.
Teng P; Zhang X; Wang H; Han X; Liu X
J Inflamm Res; 2023; 16():6257-6269. PubMed ID: 38146322
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomic analysis of gingival crevicular fluids to identify novel biomarkers of gingival recession in orthodontic patients.
Pei F; Wang M; Wang Y; Pan X; Cen X; Huang X; Jin Y; Zhao Z
J Proteomics; 2022 Aug; 266():104647. PubMed ID: 35779762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
